Jack Khouri, MD, discusses data from a multicenter study of teclistamab in patients with relapsed/refractory multiple myeloma who had prior exposure to BCMA-directed therapy.
Jack Khouri, MD
Jack Khouri, MD, is an assistant professor at Cleveland Clinic Lerner College of Medicine and Case Western Reserve University.
Articles by Jack Khouri, MD